Alcon’s annual operating income falls 16%

Operating income for Alcon in 2013 was $1.2 billion, a decline of 16% over the previous year, according to a press release from Novartis. The decline was attributed to integration and restructuring costs and was partially offset by sales growth — 3% over the previous year — and productivity gains. The Alcon surgical franchise increased by 4% in 2013 over 2012. This was driven by procedure growth, market share gains and demand for LenSx and Centurion equipment.

Full Story →